Tender Details

Country: Brazil
Summary: Acquisition of Antineoplastic and Related (Cancer) Drugs with the Objective of Supplying the Federal University Hospitals of the Ebserh Network for the Period 2025-2026.
BRT Ref No: 121844062
Deadline: 10 Jul 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 90079/2025
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Object: Electronic Auction - Acquisition of antineoplastic and related (cancer) drugs with the objective of supplying the federal university hospitals of the EBSERH network for the period 2025-2026.
UASG Code: 155007
Notice from: 06/30/2025 from 08:00 to 17:00
Proposal delivery: a from 06/30/2025 to 08:00
Gosserrelin acetate, dosage 10.80 mg, indication injectable solution
Quantity: 6013
Leupro -owl acetate, concentration 22.5 mg, pharmaceutical form liophile powder for injectable
Quantity: 12175
Nilotinibe, Concentration 200 mg
Quantity: 48035
Pegaspargasis, concentration 750 U/ml, pharmaceutical form injectable solution
Quantity: 1351
Dasatinibe, concentration 100 mg
Quantity: 17622
Fludarabine phosphate, dosage 50 mg, type injectable use
Quantity: 4394
Bleomycin sulfate, concentration 15 u, pharmaceutical form Liophile powder for injectable
Quantity: 9669
Capecitabine, 500 mg dosage
Quantity: 1839734
ANAGRELIDA HYPROID, DOSAGE 0.5 MG
Quantity: 114595
Fluoruracila, dosage 50 mg/ml, use injectable solution
Quantity: 37544
Rituximab, dosage 10mg/ml, indication injectable solution
Quantity: 4752
Leupro -owl acetate, concentration 45 mg, pharmaceutical form Liophile powder for injectable, additional characteristic with application system
Quantity: 5083
Dexrazoxane, 500 mg dosage, injectable pharmaceutical form
Quantity: 462
Hydroxyurea, dosage 500 mg
Quantity: 1772323
Cladribine, concentration 1 mg/ml, pharmaceutical form injectable solution
Amount : 1496
Abiraterone acetate, concentration 250 mg
Quantity: 460980
Bussulfano, concentration 6 mg/ml, pharmaceutical form injectable solution
Quantity: 4369
Gencitabine hydrochloride, dosage 1g, injectable use
Quantity: 35581
FULVESTERTRACT, DOSAGE 50 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, Additional Characteristics 1 ...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Acquisition of Antineoplastic and Related (Cancer) Drugs with the Objective of Supplying the Federal University Hospitals of the Ebserh Network for the Period 2025-2026. - Brazil Tender

The MINISTRY OF EDUCATION, a Government sector organization in Brazil, has announced a new tender for Acquisition of Antineoplastic and Related (Cancer) Drugs with the Objective of Supplying the Federal University Hospitals of the Ebserh Network for the Period 2025-2026.. This tender is published on BrazilTenders under BRT Ref No: 121844062 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-07-10.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.